Advertisement

Prostate Cancer Urology

Holmium Laser Enucleation vs PVP for Benign Prostatic Hyperplasia

Nov 18, 2024

The following is a summary of “A meta-analysis comparing treatment of benign prostatic hyperplasia with holmium laser enucleation and photoselective greenlight vaporization,” published in the Apri...

Radiomics and Clinical Features in Predicting B-TUEP Effectiveness

Nov 18, 2024

The following is a summary of “Clinical-radiomics combination model for predicting the short-term efficacy of bipolar transurethral enucleation of the prostate in patients with benign prostatic hype...

MRI-Based Radiomics Significantly Outperform PI-RADS v2.1 for PCa Diagnosis With PSA 4–10 ng/mL

Oct 25, 2024

The following is a summary of “Comparison in prostate cancer diagnosis with PSA 4–10 ng/mL: radiomics-based model VS. PI-RADS v2.1,” published in the October 2024 issue of Urology by Li et al. ...

Lutetium-177 Treatment Effective in Both mCRCP & mHSPC

Oct 18, 2024

In recent years, 177Lu-PSMA treatment of prostate cancer has become a major field of investigation. Results from the SPLASH and UpFrontPSMA trials, showed an improved efficacy with 177Lu-PSMA over sta...

Comparative Effectiveness of Radical Prostatectomy Techniques Based on Complication Rates

Oct 18, 2024

The following is a summary of “Comparison of the effectiveness of open, laparoscopic, and robotic-assisted radical prostatectomies based on complication rates: a retrospective observational study wi...

Role of Perinatal Allografts in Enhancing Nerve-Sparing RARP Outcomes

Oct 18, 2024

The following is a summary of “Preclinical and clinical evidence for using perinatal tissue allografts in nerve sparing robot assisted radical prostatectomy to hasten recovery of functional outcomes...

Impact of Obesity and Inflammatory Markers on PCa Prognosis

Oct 18, 2024

The following is a summary of “Investigation of association between clinically significant prostate cancer, obesity and platelet to-lymphocyte ratio and neutrophil -to-lymphocyte ratio,” published...

Impact of Sample Length as a Predictor of Cancer Detection in TPB

Oct 15, 2024

The following is a summary of “Importance of biopsy sample length for cancer diagnosis during trans-perineal prostate biopsy,” published in the September 2024 issue of Urology by Zhu et al.  ...

Oral Antithrombotic Agents Usage Tied to Worse Urinary Continence Recovery Post Robot-Assisted Radical Prostatectomy

Oct 11, 2024

The following is a summary of “Impact of oral antithrombotic agents on urinary continence recovery following robot-assisted radical prostatectomy: a retrospective cohort study,” published in the S...

Comparison of Midline and Leg Lymphoedema after Prostate Cancer Treatment

Oct 10, 2024

The following is a summary of “Characteristics of lymphoedema, in particular midline lymphoedema, after treatment for prostate cancer: a retrospective study,” published in the September 2024 issue...

RARP Perioperative & Oncologic Outcomes Poorer for Patients With OB

Oct 10, 2024

The following is a summary of “Perioperative, functional, and oncologic outcomes in obese patients undergoing Da Vinci robot-assisted radical prostatectomy: a systematic review and meta-analysis,”...

ADT Duration, Baseline Levels, & Age Influence TR Post-ADT & Prostate Radiotherapy for PCa

Sep 30, 2024

The following is a summary of “Testosterone Recovery Following Androgen Suppression and Prostate Radiotherapy (TRANSPORT): A Pooled Analysis of Five Randomized Trials from the Meta-Analysis of Rando...

Late Biochemical Recurrence in Patients with PCa After Radical Prostatectomy

Sep 30, 2024

The following is a summary of “Risk of Biochemical Recurrence and Metastasis in Prostate Cancer Patients Treated with Radical Prostatectomy After a 10-year Disease-free Interval,” published in the...

Optimal Therapeutic Sequencing & Intensified Treatment Strategies in mCRPC

Sep 27, 2024

The following is a summary of “Intensification Approaches and Treatment Sequencing in Metastatic Castration-resistant Prostate Cancer: A Systematic Review,” published in the September 2024 issue o...

VR for Enhancing Patient Understanding in Localized Prostate Cancer and Surgical Planning

Sep 27, 2024

The following is a summary of “Virtual Reality as an Adjunct to traditional patient counseling in Patients with newly-diagnosed localized prostate cancer,” published in the September 2024 issue of...

Evidence-Based Guidelines for Workup and Salvage Treatment of IPR-PC

Sep 26, 2024

The following is a summary of “American Radium Society Appropriate Use Criteria for the Workup and Treatment of Local Intraprostatic Recurrence of Prostate Cancer Following Definitive Radiotherapy,â...

Predictive Modeling of Incidental Prostate Cancer Risk in Benign Prostatic Hyperplasia Surgery

Sep 26, 2024

The following is a summary of “Incidental Prostate Cancer in Patients Undergoing Surgery for Benign Prostatic Hyperplasia: A Predictive Model,” published in the September 2024 issue of Urology by ...

Role of Serial mpMRI and PSA Increase in Upgrading PIRADS Lesions

Sep 24, 2024

The following is a summary of “Natural history of PIRADS-2 lesions on serial multiparametric magnetic resonance imaging: Real-life data from an Academic Center,” published in the September 2024 is...

Outcomes of Salvage Treatments for Recurrent Prostate Cancer

Sep 24, 2024

The following is a summary of “Salvage local treatment for recurrent prostate cancer after focal therapy: A systematic review and meta-analysis,” published in the September 2024 issue of Urology b...

Liquid Biopsy Predicts Docetaxel Futility & Identifies Resistance Biomarkers in mCRPC

Sep 20, 2024

The following is a summary of “Liquid Biopsy in Progressing Prostate Cancer Patients Starting Docetaxel with or Without Enzalutamide: A Biomarker Study of the PRESIDE Phase 3b Trial,” published in...

SUBSPECIALTIES

Advertisement